This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer Logo
BAYERPROYour Resource Portal
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Women's Health
  • Jaydess® ▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Ophthalmology
  • Eylea® (aflibercept) 8mg
Products
  • Cardiology
  • Oncology
  • Ophthalmology
  • Women's Health
  • Cardiology Resources
  • Oncology Resources
  • Ophthalmology Resources
  • Women's Health Resources
  • Bayer Events & On Demand Webinars
  • Cardiology Events & On Demand Webinar
  • Oncology Events & On Demand Webinars
  • Ophthalmology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Cardiology Learning Zone
  • Oncology Learning Zone
  • Ophthalmology Learning Zone
  • Women's Health Learning Zone
  • Cardiology Podcasts
  • Oncology Podcasts
  • Ophthalmology Podcasts
closesearch
Recent Searches
    You are now leaving BayerPRO

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    BayerPRO IRE Above Brand Header

    Ophthalmology

    EYLEA® (aflibercept) | Medical Information Contact
    EYLEA Prescribing Information
    PP-PF-OPHT-IE-0025-1, December 2025
    EYLEA® (aflibercept) 8mg | Resources
    Discover some resources below that you can access to learn more about EYLEA 8mg in nAMD and DME.
    EYLEA Prescribing Information
    PP-EYL_8mg-IE-0160-1, January 2026

    Women's Health

    View more
    Endometrial Hyperplasia
    Explore more about assessing and managing Endometrial Hyperplasia.
    PP-MIR-IE-0075-1, February 2026
    Menorrhagia (HMB - Heavy Menstural Bleeding)
    Assessing and managing women with heavy menstrual bleeding.
    PP-MIR-IE-0074-1, January 2026
    Contraception
    Learn about contraception & helping your patients make the right choice.
    PP-MIR-IE-0073-1, January 2026
    Medical Information Contact
    Qlaira® (Estradiol valerate/dienogest)
    Qlaira® Prescribing Information
    PP-QLA-IE-0008-1, January 2026